ENZON PHARMACEUTICALS INC (ENZN) is a publicly traded company in the Unknown sector. Across all available filings, 36 corporate insiders have executed 445 transactions totaling $13.7M, demonstrating a bearish sentiment with -$1.9M in net insider flow. The most recent transaction on Jun 16, 2023 involved a purchase of 84,550 shares valued at $11.8K.
No significant insider buying has been recorded for ENZN in the recent period.
No significant insider selling has been recorded for ENZN in the recent period.
Based on recent SEC filings, insider sentiment for ENZN is bearish with an Insider Alignment Score of 43/100 and a net flow of -$1.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ENZON PHARMACEUTICALS INC (ENZN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 36 insiders are actively trading ENZN stock, having executed 445 transactions in the past 90 days. The most active insider is Ivan D. Horak (Executive), who has made 50 transactions totaling $6.6M.
Get notified when executives and directors at ENZN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | C. Read Randolph | Executive | Purchase | 84,550 | $0.14 | $11.8K | |
| Jun 14, 2023 | C. Read Randolph | Executive | Purchase | 15,000 | $0.13 | $1.9K | |
| Aug 13, 2021 | Xstelos Corp. | Executive | Sale | 50,000 | $0.39 | $19.5K | |
| Aug 13, 2021 | Xstelos Corp. | Executive | Sale | 57,500 | $0.39 | $22.4K | |
| Nov 18, 2020 | C. Read Randolph | Executive | Purchase | 50,000 | $0.16 | $8.0K | |
| Nov 16, 2020 | C. Read Randolph | Executive | Purchase | 50,450 | $0.15 | $7.6K | |
| Nov 13, 2020 | Bleznick Jordan | Executive | Purchase | 100,000 | $0.15 | $15.0K | |
| Oct 9, 2020 | C. Icahn Carl | Executive | Exercise | 39,277 | $N/A | $0 | |
| Oct 9, 2020 | C. Icahn Carl | Executive | Exercise | 29,457,750 | $N/A | $0 | |
| Aug 25, 2020 | Couchman Jonathan | Executive | Sale | 25,000 | $0.19 | $4.8K | |
| Aug 24, 2020 | Couchman Jonathan | Executive | Sale | 52,100 | $0.18 | $9.4K | |
| Aug 5, 2020 | Fund Couchman Family | Executive | Purchase | 506,292 | $0.20 | $101.3K | |
| Mar 26, 2020 | Xstelos Corp. | Executive | Purchase | 160,785 | $0.14 | $22.5K | |
| Mar 26, 2020 | Fund Couchman Family | Executive | Purchase | 160,785 | $0.14 | $22.5K | |
| Mar 25, 2020 | Xstelos Corp. | Executive | Purchase | 469,551 | $0.14 | $65.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 39 | $7.8M | 31.1% |
Purchase(P) | 139 | $5.9M | 23.5% |
Exercise(M) | 99 | $4.8M | 19.0% |
Other(J) | 53 | $4.2M | 16.7% |
Payment(F) | 42 | $2.4M | 9.4% |
Award(A) | 65 | $75.0K | 0.3% |
Exercise (Options)(X) | 4 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 1 | $0 | 0.0% |
Insider activity at ENZON PHARMACEUTICALS INC shows mixed signals across all time. While $5.9M in purchases indicates some executive confidence,$7.8M in sales balances the picture, resulting in a modest net flow of -$1.9M.36 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Ivan D. Horak, has transacted $6.6M during this period.